Cyclodextrins with Carboxylic Acids Group as Potential Chemzymes
COOH), 99.64, 99.48, 99.46, 99.43, 99.27, 99.26, 99.12, 99.10,
(
OCH
3.96–3.92 (m, 2 H, 6-H), 3.89 (dd, J = 10.8, 3.9 Hz, 1 H, 6-H), 3.69
[s, 3 H, 1ϫ OCH (C-3)], 3.67 [s, 3 H, 1ϫ OCH (C-3)], 3.54 [s, 3
(C-3)], 3.52 [m, 6 H, 2ϫ OCH (C-3)], 3.50 [s, 3 H,
(C-2)], 3.49 [s, 3 H, 1ϫ OCH (C-2)], 3.45 [s, 3 H, 1ϫ
(C-2)], 3.42 [m, 6 H, 1ϫ OCH (C-2)], 3.81–3.36 (m, 32 H,
4ϫ 6-H, 7ϫ 5-H, 7ϫ 4-H, 7ϫ 6Ј-H, 7ϫ 3-H), 3.33–3.22 [m, 25
2 2
COOH), 4.21 (dd, J = 17.1, 3.9 Hz, 2 H, OCH COOH),
9
8
8.89, 98.87, 98.79 (C-1), 82.72, 82.49, 82.33, 82.05, 81.99, 81.94,
1.87, 81.68, 81.62, 81.31, 81.19, 80.78, 80.67, 80.55, 80.24, 79.79
3
3
(
C-2, C-3, C-4), 71.88, 71.64, 71.50, 71.39, 71.34, 71.28, 71.22, H, 1ϫ OCH
1.15, 71.01, 70.80, 70.42 (C-6, C-5, OCH COOH), 68.69 (OCH 1ϫ OCH
COOH), 62.44, 61.80, 61.71, 61.68, 61.60, 61.57, 61.41, 61.25, 61.22 OCH
OCH (C-3)], 59.22, 59.14, 59.11, 59.05, 58.68, 58.66, 58.52, 58.49,
8.47, 58.42, 58.40 [OCH (C-6), OCH (C-2)] ppm. HRMS
MALDI-TOF): calcd. for 39Na 1539.667; found
539.729.
3
3
7
2
2
-
3
3
3
3
[
3
1
3
5
(
3
3
H, 7ϫ OCH
NMR (126 MHz, CDCl
(COOH), 99.82, 99.66, 99.64, 99.50, 99.47, 99.16, 98.88, 98.87,
3
(C-6), 4ϫ 2-H], 3.14–3.08 (m, 3 H, 2-H) ppm.
C
+
C
65
H
112
O
3
): δ = 172.12, 172.10, 171.44, 171.41
1
9
8
7
7
6
5
8.76 (C-1), 82.71, 82.57, 81.93, 81.82, 81.59, 81.49, 81.44, 81.36,
1.08, 80.90, 80.47, 80.44, 80.14, 80.03, 79.87 (C-2, C-3, C-4),
2.12, 72.02, 71.94, 71.54, 71.45, 71.38, 71.33, 71.10, 71.04, 70.94,
2A-O-Carboxymethyl-per-O-methyl-β-cyclodextrin (20): Compound
6 (42.2 mg, 0.029 mmol) was subjected to the procedure for the
preparation of 19 to give 20 as a white foam (31 mg, 73%). R
.29 (H O/2-propanol/EtOAc, 1:3:3). [α] = +69.2 (c = 0.7,
): δ = 5.18 (d, J = 3.6 Hz, 1
H, 1-H), 5.14 (dd, J = 8.8, 3.7 Hz, 2 H, 1-H), 5.10 (dd, J = 4.6,
1
f
=
0.88, 70.52, 70.45 (C-6, C-5, OCH
2.53, 62.48, 61.66, 61.64, 61.43, 61.18 [OCH
9.05, 58.83, 58.80, 58.43, 58.39, 58.20 [OCH
2
COOH), 68.71 (OCH
(C-3)], 59.23, 59.11,
(C-6), OCH (C-2)]
43Na 1627.647;
2
COOH),
0
2
1
D
3
3 3
CHCl ). H NMR (500 MHz, CDCl
3
3
+
ppm. HRMS (MALDI-TOF): calcd. for C67
found 1627.891.
112
H O
3
.8 Hz, 2 H, 1-H), 5.07 (d, J = 3.5 Hz, 1 H, 1-H), 4.97 (d, J =
.4 Hz, 1 H, 1-H), 4.45 (d, J = 16.5 Hz, 1 H, OCH COOH), 4.20
COOH), 3.98 (dd, J = 10.2, 3.1 Hz, 1
H, 6-H), 3.90–3.75 (m, 12 H, 6-H, 5-H), 3.72–3.45 [m, 61 H, 5-H,
-H, OCH (C-3), 6Ј-H, OCH (C-2), 3-H], 3.39–3.34 [m, 22 H,
(C-6), 2-H], 3.21–3.17 (m, 6 H, 2-H) ppm. 1 C NMR
OCH
126 MHz, CDCl ): δ = 170.83 (COOH), 99.63, 99.54, 99.52, 99.20,
3
2
Procedure for Determining the Rate of Hydrolysis: Each assay was
performed on samples (1 mL) prepared from aqueous solutions of
the appropriate nitrophenyl glycoside (0.5 mL) at different concen-
trations mixed with phosphate buffer (0.5 m, 0.5 mL) containing
either 7–9 or 19–22 (0.58 mm) or nothing as control. The reactions
were monitored at 59 °C by using UV absorption at 400 nm and
typically monitored for 12 h. Rates were calculated from the slope
of the progress curve of each reaction. Uncatalysed rates were ob-
tained directly from the control samples. Catalyzed rates were cal-
culated by subtracting the uncatalysed rate from the rate obtained
from the appropriate cyclodextrin-containing sample. The cata-
lyzed rates were used to construct a Hanes plot ([S]/V vs. [S]) from
(d, J = 16.4 Hz, 1 H, OCH
2
4
3
3
3
3
(
3
9
8
4
7
6
5
9.15, 98.94, 98.91 (C-1), 82.62, 82.36, 82.14, 82.04, 81.95, 81.90,
1.77, 81.61, 81.33, 80.79, 80.63, 80.38, 79.93, 79.55 (C-2, C-3, C-
), 72.09, 71.98 (C-6), 71.88 ( C-5), 71.66, 71.58 (C-6), 71.25, 71.04,
A
A
0.97, 70.88 (C-5), 70.61 ( C-6), 69.78 (OCH
2
COOH), 61.71,
(C-3)], 59.39, 59.36, 59.30,
9.26, 59.16, 59.11, 59.01, 58.92, 58.48, 58.45, 58.34, 58.33 [OCH
(C-2)] ppm. HRMS (MALDI-TOF): calcd. for
37Na+ 1495.677; found 1495.597.
1.64, 61.58, 61.55, 61.40, 61.20 [OCH
3
3
(C-6), OCH
3
which Km and Vmax were determined. kcat was calculated as Vmax
/
C
64 112
H O
[cyclodextrin]; kuncat was determined as the slope from a plot of
3A-O-Carboxymethyl-per-O-methyl-β-cyclodextrin (21): Compound
7 (305 mg, 0.21 mmol) was subjected to the procedure for the
preparation of 19 to give 21 as a white foam (221 mg, 1%). R
.31 (H O/2-propanol/EtOAc, 1:3:3). [α] = +122.3 (c = 1.0,
): δ = 5.71 (d, J = 3.4 Hz, 1
H, 1-H), 5.14–5.13 (m, 2 H, 1-H), 5.10–5.08 (m, 3 H, 1-H), 5.05
d, J = 3.7 Hz, 1 H, 1-H), 4.58 (d, J = 17.6 Hz, 1 H, OCH COOH),
COOH), 4.11 (dd, J = 10.7, 2.8 Hz,
H, 6-H), 3.87–3.67 (m, 15 H, 6-H, 5-H, A4-H, A3-H), 3.66–3.44
(C-3), 6Ј-H, OCH (C-2), 3-H], 3.40–3.33
(C-6)], 3.29 (dd, J = 9.8, 3.4 Hz, 1 H, 2-H), 3.23
V
uncat vs. [S]. The following extinction coefficients were determined
1
–1
–1
and used in the calculations: ε = 17.04 mm cm (pH = 8.0, 59 °C,
f
=
4-nitrophenolate), ε = 2.28 mm cm (pH = 8.0, 59 °C, 2-nitro-
–1
–1
0
2
1
D
phenolate).
3 3
CHCl ). H NMR (500 MHz, CDCl
Supporting Information (see footnote on the first page of this arti-
cle): H and C NMR spectra of compounds.
1
13
(
2
4.45 (d, J = 17.6 Hz, 1 H, OCH
2
1
Acknowledgments
[
m, 58 H, 4-H, OCH
m, 21 H, OCH
dd, J = 9.4, 3.5 Hz, 1 H, 2-H), 3.19–3.14 (m, 5 H, 2-H) ppm.
NMR (126 MHz, CDCl ): δ = 172.45 (COOH), 99.80, 99.50, 99.41,
9.31, 99.00, 98.95, 98.91 (C-1), 82.69, 82.66, 82.54, 82.29, 82.21,
3
3
[
3
We thank the Free Danish National Research Council (FNU) and
the Lundbeck Foundation for financial support.
1
3
(
C
3
9
8
8
[
[
1] R. Wolfenden, Acc. Chem. Res. 2001, 34, 938–945.
2] J. Bjerre, C. Rousseau, L. Marinescu, M. Bols, Appl. Microbiol.
Biotechnol. 2008, 81, 1–11.
3] a) H. Tsutsumi, H. Ikeda, H. Mihara, A. Ueno, Bioorg. Med.
Chem. Lett. 2004, 14, 723–726; b) H. Tsutsumi, H. Ikeda, H.
Mihara, A. Ueno, Bioorg. Med. Chem. Lett. 2004, 14, 723–
726; c) M. Fukudome, K. Shimosaki, K. Koga, D.-Q. Yuan,
K. Fujita, Tetrahedron Lett. 2007, 48, 7493–7497; d) Y.-H.
Zhou, M. Zhao, Z.-W. Mao, L.-N. Ji, Chem. Eur. J. 2008, 14,
2.13, 82.05, 81.94, 81.89, 81.76, 81.43, 81.29, 80.88, 80.85, 80.72,
0.48, 80.40, 80.30, 80.25 (C-2, C-3, C-4, C-3, AC-4), 71.82
A
A
(OCH
2
COOH), 71.72, 71.67 (C-6), 71.54 ( C-5), 71.48 (C-6), 71.37,
[
A
7
6
5
1.18, 71.10, 71.05, 71.01, 70.89 (C-5), 70.55 ( C-6), 61.96, 61.73,
1.70, 61.57, 61.54, 61.52 [OCH (C-3)], 59.17, 59.11, 59.09, 59.03,
8.94, 58.73, 58.66, 58.55, 58.51, 58.13 [OCH (C-6), OCH (C-2)]
37Na 1495.677;
3
3
3
+
ppm. HRMS (MALDI-TOF): calcd. for C64
found 1495.691.
112
H O
7193–7201; e) A. Fragoso, R. Cao, M. Banõs, Tetrahedron Lett.
2A,3 ,2 ,3 -O-Tetracarboxymethyl-per-O-methyl-β-cyclodextrin
22): Compound 18 (180 mg, 0.117 mmol) was subjected to the pro-
cedure for the preparation of 19 to give 22 as a white foam (118 mg,
3%). R = 0.44 (H O/2-propanol/EtOAc, 1:2:2, 0.5% formic acid).
α] = +112.1 (c = 1.0, CHCl
.17 (d, J = 3.4 Hz, 1 H, 1-H), 5.09 (t, J = 3.5 Hz, 2 H, 1-H), 5.04
B
D
E
2004, 45, 4069–4071.
[
[
4] L. Marinescu, M. Bols, Trends Glycosci. Glycotechnol. 2009,
(
21, 309–323.
5] A. Vasella, G. J. Davies, M. Boehm, Curr. Opin. Chem. Biol.
002, 6, 619–629.
6
[
f
2
2
1
D
3 3
). H NMR (500 MHz, CDCl ): δ =
[
6] M. L. Sinnott, Chem. Rev. 1990, 90, 1171–1202.
7] T. Ohe, Y. Kajiwara, T. Kida, W. Zhang, Y. Nakatsuji, I. Ikeda,
Chem. Lett. 1999, 921–922.
5
[
(t, J = 3.3 Hz, 2 H, 1-H), 5.00 (d, J = 3.3 Hz, 1 H, 1-H), 4.98 (d,
J = 3.4 Hz, 1 H, 1-H), 4.53 (dd, J = 17.5, 2.0 Hz, 2 H, OCH
2
-
[8] T. H. Doug, J. Z. Chou, X. Huang, A. J. Bennet, J. Chem. Soc.
Perkin Trans. 2 2001, 83–89.
2
COOH), 4.37–4.34 (m, 2 H, OCH COOH), 4.31–4.27 (m, 2 H,
Eur. J. Org. Chem. 2012, 4063–4070
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
4069